Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy

Fig. 1

Clinical data of patient before and after autologous OM-MSC therapy. A A 26-year-old female suffered from chronic refractory seizures for 17 years. B The ambulatory electroencephalography (AEEG) was recorded the process of epileptogenesis in 2014 and 2015, before and after autologous OM-MSC therapy. C The clinical condition of patient by taking pictures in 2014 before autologous OM-MSC therapy, and follow-up in 2015 and 2018 after autologous OM-MSC therapy. D Brain magnetic resonance imaging (MRI) showed obviously focal malacia localizing in the bilateral temporal region as well as moderate generalized cerebral atrophy in 2012 before autologous OM-MSC therapy. E MRI showed no obviously changes in intracranial structure in 2015 relative to in 2014 (before OM-MSCs transplantation)

Back to article page